CEACAM5 and neoplasm: Baseline tumor-marker means were 12.0 ± 4.0 U/mL for CA 15 − 3, 2.10 ± 1.10 ng/mL for CEA and 16 ± 6 U/mL for CA 125 (Table 1 ).Technical success was 98.8% (79/80) with a mean procedure time of 18 ± 5 min; minor 30‐day complications occurred in 7/80 (8.8%), mostly grade I, and 24‐h pain was low (VAS 2.3 ± 1.1) (Table 2).